Collegium Pharmaceutical and Boston Legacy FC Expand Their Partnership Beyond Matchday to Communities Across Massachusetts

New multi-year partnership combines youth coach training, an annual Sports for All Summit, and sensory inclusion programs to support neurodivergent children and families

STOUGHTON, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, and Boston Legacy FC, Boston’s professional women’s soccer club, today announced an expanded, multi-year partnership to deepen their commitment to Boston communities and create more opportunities for neurodivergent children and families, including those living with attention-deficit/hyperactivity disorder (ADHD).

Building on their existing Collegium Sensory Room partnership, Collegium and Boston Legacy FC will help youth soccer coaches better support neurodivergent children and bring families, experts and community leaders together through an annual Collegium Summit: Sports for All. The expanded partnership extends their work beyond matchday into communities across Massachusetts and deepens Collegium’s local commitment ahead of its headquarters move to Boston in early 2027.

ADHD is common among school-age children. The Centers for Disease Control and Prevention (CDC) reports, based on 2022 National Survey of Children’s Health data, that 10.5% of U.S. children aged 3–17, or 6.5 million children, have ever received an ADHD diagnosis.¹ Published research indicates that children with ADHD may participate in youth sports less often and less successfully, and that youth sport coaches have reported less positive attitudes about including these children on their teams.² The partnership’s new programs will help coaches better support children with ADHD and bring families and experts together to explore ways to make sports more accessible and inclusive.

“As a leader in ADHD, Collegium recognizes the importance of addressing every part of life that matters to those living with ADHD and their families, from the classroom to the soccer pitch to the dinner table,” said Vikram Karnani, President and Chief Executive Officer, Collegium Pharmaceutical. “We believe healthier people and stronger communities go hand in hand. Our partnership with Boston Legacy FC puts that belief into action by helping children participate in sports, build friendships and feel included, and by giving coaches practical training to support them. Massachusetts is where we begin, and we will keep growing this effort for families everywhere.”

The expanded partnership includes:

• Soccer Coaching Certification Initiative: Boston Legacy FC and Collegium will launch a coaching certification initiative to equip coaches to better support kids with ADHD and other neurodevelopmental conditions. Coaches will have the opportunity to earn a certification recognizing their completion of the training. The initiative is planned to launch in Massachusetts in 2027 and continue through 2029, with regional and national expansion envisioned.
• Annual Collegium Summit: Sports for All: Boston Legacy FC will host an annual Collegium Sports for All Summit at its new Performance Center in Brockton, Mass., bringing together patients, caregivers, medical professionals, advocates, athletes and community leaders to discuss accessibility, neurodiversity and participation in sports. The gathering will provide a forum to share experiences and explore ways to better support neurodivergent children and families.
• Continued Sensory Inclusion: The partnership will continue to support the Collegium Sensory Room, which provides a quieter space for fans who need a break from the noise, crowds and visual stimulation of matchday.
  
  

The partnership also includes an increased presence for Collegium as an Official Partner of Boston Legacy FC. Collegium’s logo will appear on the upper back of all Boston Legacy FC game kits, including the primary, secondary and goalkeeper kits, at every home and away match. Collegium will also have permanent signage on the press box at White Stadium, joining the club’s other long-term partners.

“We’re proud to expand our partnership with Collegium and build on our shared commitment to making soccer more inclusive and accessible. From featuring Collegium on our kits to expanding our community initiatives, this partnership allows us to extend our impact beyond the pitch and create meaningful opportunities for children and families to feel welcomed, supported and connected through sport,” said Amina Bulman, Chief Revenue Officer of Boston Legacy FC. “We’re excited about what we can achieve together and the meaningful, lasting impact we can make in our communities.”

The expanded partnership builds on community programming already underway. On Oct. 24, 2026, Collegium presented an adaptive soccer clinic in collaboration with Boston Legacy FC, UMass Shriver Center, and Mass Youth Soccer. The clinic, held at SBLI Fields at Progin Park, paired children with volunteer buddies for a supportive soccer experience, providing an early example of the inclusive community programming.

ABOUT COLLEGIUM PHARMACEUTICAL

Collegium Pharmaceutical is a dynamic biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system (CNS) and pain conditions. Collegium has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions.

With a portfolio of differentiated ADHD medications and an established leadership position in responsible pain management, Collegium leads with the scientific rigor and commercial expertise to deliver treatment options around how people live their lives.

For more information, please visit collegiumpharma.com or find us on LinkedIn.

ABOUT BOSTON LEGACY FC

Boston Legacy FC is the 15^th team in the National Women’s Soccer League (NWSL), currently playing its inaugural season at Gillette Stadium and Centreville Bank Stadium. Founded and led by women, the club is committed to creating a home for the greatest female athletes of our time, building upon the supercharged legacy of Boston’s historic sports teams, cultivating a community of fans with impact at its core, and forging new connections across our city through sport. For more information, please visit bostonlegacyfc.com or its social media platforms – LinkedIn, Instagram, Twitter (X), Tiktok, Bluesky, Facebook

MEDIA CONTACTS

Boston Legacy FC Media Contact
Sara Rooke
Director of Communications, Boston Legacy FC
srooke@bostonlegacyfc.com
617-872-9453

Collegium Media Contact
Jessica Cotrone
Senior Vice President, Corporate Communications & Corporate Affairs
communications@collegiumpharma.com

REFERENCES

1. Danielson ML, et al. ADHD Prevalence Among U.S. Children and Adolescents in 2022. Journal of Clinical Child & Adolescent Psychology, 2024;53(3):343–360. https://stacks.cdc.gov/view/cdc/160350

2. O’Connor BC, Fabiano GA, et al. Effects of a Summer Treatment Program on Functional Sports Outcomes in Young Children with ADHD. PubMed Central. Cites Beyer et al., 2008, International Journal of Sports Science & Coaching, 3, 555–563, for coach attitudes. https://pmc.ncbi.nlm.nih.gov/articles/PMC4399495

Photos accompanying this announcement are available at: 
https://www.globenewswire.com/NewsRoom/AttachmentNg/1a410b80-fea3-4a0b-9b4a-89ea849a75d7
https://www.globenewswire.com/NewsRoom/AttachmentNg/518a5af8-5b64-40e0-af62-774efda33cdf
https://www.globenewswire.com/NewsRoom/AttachmentNg/36916660-abce-4652-9943-64a9f9d07338
https://www.globenewswire.com/NewsRoom/AttachmentNg/81302822-75e7-474b-84bd-782639b75130
https://www.globenewswire.com/NewsRoom/AttachmentNg/0ff18e8f-8874-49cf-a0ae-0d4f99c9ed25